Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verastem (VSTM) Common Equity: 2018-2025

Historic Common Equity for Verastem (VSTM) over the last 8 years, with Sep 2025 value amounting to -$15.5 million.

  • Verastem's Common Equity fell 240.38% to -$15.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$15.5 million, marking a year-over-year decrease of 240.38%. This contributed to the annual value of -$28.9 million for FY2024, which is N/A change from last year.
  • According to the latest figures from Q3 2025, Verastem's Common Equity is -$15.5 million, which was down 143.06% from $36.1 million recorded in Q2 2025.
  • Over the past 5 years, Verastem's Common Equity peaked at $102.6 million during Q1 2021, and registered a low of -$32.4 million during Q1 2025.
  • Over the past 3 years, Verastem's median Common Equity value was $22.0 million (recorded in 2024), while the average stood at $23.2 million.
  • Over the last 5 years, Verastem's Common Equity had its largest YoY gain of 91.27% in 2025, and its largest YoY loss of 240.38% in 2025.
  • Verastem's Common Equity (Quarterly) stood at $87.6 million in 2021, then tumbled by 45.88% to $47.4 million in 2022, then surged by 32.30% to $83.2 million in 2023, then slumped by 86.70% to -$28.9 million in 2024, then plummeted by 240.38% to -$15.5 million in 2025.
  • Its Common Equity stands at -$15.5 million for Q3 2025, versus $36.1 million for Q2 2025 and -$32.4 million for Q1 2025.